Vi-Jon Clears Major Hurdle in Chapter 11 as Court Approves Vote on Talc Settlement Plan
Vi-Jon has received court clearance to solicit creditor votes on its Chapter 11 reorganization plan, aiming to resolve widespread talc-related liabilities.

Under the court-approved disclosure framework, claimants and financial creditors will weigh in on the proposed restructuring path, which seeks to insulate the company's core manufacturing operations while establishing a dedicated trust mechanism to address legacy tort liabilities.
Navigating the Mass-Tort Restructuring Landscape
Vi-Jon, widely known for manufacturing Germ-X hand sanitizer alongside an expansive portfolio of private-label health and beauty goods for major national retailers, turned to Chapter 11 protection following an escalating wave of personal injury lawsuits. The litigation centered on allegations that legacy cosmetic talc products contained asbestos contamination linked to severe health conditions, including mesothelioma and ovarian cancer.
The strategic recourse to Chapter 11 reflects a broader corporate trend across the consumer products and healthcare sectors, where companies face mounting legal defense costs and unpredictable jury verdicts stemming from legacy product formulations. By utilizing the federal bankruptcy code, Vi-Jon intends to centralize thousands of individual lawsuits into a single, equitable claims resolution facility.
Key Components of the Proposed Reorganization Plan
The approved solicitation package outlines a blueprint designed to balance creditor recovery with operational viability:
* Dedicated Settlement Trust: Establishment of a liquidating or settlement trust funded by corporate contributions and potential insurance proceeds to evaluate and disburse compensation to verified talc claimants. * Operational Continuity: Protection for ongoing manufacturing hubs, supply chain arrangements, and commercial retail partnerships, ensuring that everyday distribution remains uninterrupted. * Release of Claims: Clear channel injunctions intended to shield reorganized entities and commercial retail distributors from future civil litigation arising from legacy talc distributions. * Capital Structure Realignment: Reorganization of existing balance sheet debt to position the surviving manufacturing arm with a sustainable leverage ratio.
Market Impact and Industry Precedents
Restructuring specialists and distressed-debt investors are closely tracking Vi-Jon's proceedings as legal precedents continue to evolve around Chapter 11 mass-tort resolutions. Federal appellate courts have maintained heightened scrutiny over non-debtor third-party releases and the structural legitimacy of corporate divisive mergers, pushing debtors toward tightly negotiated consensual plans supported by statutory majorities.
For Vi-Jon, securing sufficient stakeholder consensus during the voting window is paramount. Approval will require an affirmative vote from qualified majorities within impaired voting classes, particularly tort claimants whose treatment forms the structural backbone of the resolution.
If the voting process concludes favorably and the bankruptcy court grants final plan confirmation, Vi-Jon will emerge with a streamlined corporate profile, shedding balance-sheet overhangs that have constrained capital deployment and strategic investment across its manufacturing base.
About Marcus Vance
Chief Financial Editor & Global Markets Strategist
Chief Financial Editor and senior markets strategist covering Wall Street, macroeconomic policy, corporate finance, and global trade for Finance News 365.


